Vergani D - Search Results

1

Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure.

Antoniades CG, Berry PA, Davies ET, Hussain M, Bernal W, Vergani D, Wendon J. Antoniades CG, et al. Among authors: vergani d. Hepatology. 2006 Jul;44(1):34-43. doi: 10.1002/hep.21240. Hepatology. 2006. PMID: 16799971

2

Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.

Senaldi G, Peakman M, McManus T, Davies ET, Tee DE, Vergani D. Senaldi G, et al. Among authors: vergani d. J Infect Dis. 1990 Dec;162(6):1227-32. doi: 10.1093/infdis/162.6.1227. J Infect Dis. 1990. PMID: 1977807

3

Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease.

Lobo-Yeo A, Senaldi G, Portmann B, Mowat AP, Mieli-Vergani G, Vergani D. Lobo-Yeo A, et al. Among authors: vergani d. Hepatology. 1990 Aug;12(2):224-32. doi: 10.1002/hep.1840120208. Hepatology. 1990. PMID: 2118117

4

Effect of initiation of insulin therapy on T-lymphocyte activation in type 1 diabetes.

Peakman M, Hussain MJ, Millward BA, Leslie RD, Vergani D. Peakman M, et al. Among authors: vergani d. Diabet Med. 1990 May;7(4):327-30. doi: 10.1111/j.1464-5491.1990.tb01399.x. Diabet Med. 1990. PMID: 2140085

5

Reduction of complement activation during bypass by prime manipulation.

Bonser RS, Dave JR, Davies ET, John L, Taylor P, Gaya H, Lennox SC, Vergani D. Bonser RS, et al. Among authors: vergani d. Ann Thorac Surg. 1990 Feb;49(2):279-83. doi: 10.1016/0003-4975(90)90150-5. Ann Thorac Surg. 1990. PMID: 2306150

6

Complement activation before, during and after cardiopulmonary bypass.

Bonser RS, Dave JR, John L, Gademsetty MK, Carter PG, Davies E, Taylor P, Gaya H, Lennox SC, Vergani D. Bonser RS, et al. Among authors: vergani d. Eur J Cardiothorac Surg. 1990;4(6):291-6. doi: 10.1016/1010-7940(90)90204-d. Eur J Cardiothorac Surg. 1990. PMID: 2361017

7

Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood.

Mieli-Vergani G, Lobo-Yeo A, McFarlane BM, McFarlane IG, Mowat AP, Vergani D. Mieli-Vergani G, et al. Among authors: vergani d. Hepatology. 1989 Feb;9(2):198-203. doi: 10.1002/hep.1840090206. Hepatology. 1989. PMID: 2521474

8

Detection of anti-liver cell membrane antibody using a human hepatocellular carcinoma cell line.

Lobo-Yeo A, McSorley C, McFarlane BM, Mieli-Vergani G, Mowat AP, Vergani D. Lobo-Yeo A, et al. Among authors: vergani d. Hepatology. 1989 Feb;9(2):210-4. doi: 10.1002/hep.1840090208. Hepatology. 1989. PMID: 2536348

9

Increased activated T-lymphocytes and normal thyrotropin receptor antibody levels in Graves' disease in long-term remission.

Peakman M, Hussain M, Cundy T, Vergani D. Peakman M, et al. Among authors: vergani d. J Clin Lab Immunol. 1989 Sep;30(1):1-5. J Clin Lab Immunol. 1989. PMID: 2577115

10

Anti-lymphocytic antibodies in autoimmune chronic active hepatitis starting in childhood.

Donaldson PT, Hussain MJ, Mieli-Vergani G, Mowat AP, Vergani D. Donaldson PT, et al. Among authors: vergani d. Clin Exp Immunol. 1989 Jan;75(1):41-6. Clin Exp Immunol. 1989. PMID: 2784729 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

444 results

Search Page

Filters